Capricor Therapeutics | CAPR - Interest Expense On Debt


Capricor Therapeutics reported 3.05M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Bioline Rx USD 360K 84K Sep/2025
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cipla INR 140.3M 8.5M Dec/2025
Cytokinetics USD 30.33M 4.01M Dec/2025
Geron USD 7.3M 1.35M Dec/2025
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 197K 222K Dec/2025
J&J USD 43M 25M Mar/2026
Plus Therapeutics USD 62K 25K Dec/2023
Prothena USD 2.62M 350M Dec/2025
PTC Therapeutics USD 50.58M 2.59B Dec/2025
Sarepta Therapeutics USD 7.56M 2.33M Sep/2025